JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 3 filers reported holding JUNO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $571,000 | +17.7% | 12,492 | +15.6% | 0.00% | +33.3% |
Q3 2017 | $485,000 | +50.2% | 10,810 | 0.0% | 0.00% | +50.0% |
Q2 2017 | $323,000 | +34.6% | 10,810 | +0.1% | 0.00% | 0.0% |
Q1 2017 | $240,000 | +17.6% | 10,799 | -0.2% | 0.00% | 0.0% |
Q4 2016 | $204,000 | -37.2% | 10,824 | -0.1% | 0.00% | -33.3% |
Q3 2016 | $325,000 | -21.9% | 10,831 | +0.1% | 0.00% | 0.0% |
Q2 2016 | $416,000 | +18.9% | 10,824 | +17.8% | 0.00% | 0.0% |
Q1 2016 | $350,000 | +1958.8% | 9,191 | +2299.7% | 0.00% | – |
Q4 2015 | $17,000 | +13.3% | 383 | +0.8% | 0.00% | – |
Q3 2015 | $15,000 | -25.0% | 380 | -1.0% | 0.00% | – |
Q2 2015 | $20,000 | – | 384 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Biomark Capital Management Co. LLC | 2,168,601 | $65,080,000 | 86.12% |
Crestline Management, LP | 17,348,799 | $520,637,000 | 66.02% |
Omega Fund Management, LLC | 1,229,512 | $36,898,000 | 28.17% |
SIB LLC | 100,000 | $3,001,000 | 2.42% |
Clarius Group, LLC | 117,896 | $3,538,000 | 1.65% |
BB BIOTECH AG | 1,405,000 | $42,164,000 | 1.48% |
Duquesne Family Office | 493,000 | $14,795,000 | 1.31% |
First Washington CORP | 65,320 | $1,960,000 | 1.10% |
PFM Health Sciences, LP | 1,124,285 | $33,740,000 | 0.99% |
Partner Investment Management, L.P. | 18,376 | $551,000 | 0.82% |